Kite pharma stock price full#

Compare Standard and Premium Digital here.Īny changes made can be done at any time and will become effective at the end of the trial period, allowing you to retain full access for 4 weeks, even if you downgrade or cancel. You may also opt to downgrade to Standard Digital, a robust journalistic offering that fulfils many user’s needs. Price/Sales - Latest closing price of the stock divided by the last twelve months revenue/sales per share. If you’d like to retain your premium access and save 20%, you can opt to pay annually at the end of the trial. Company profile for Kite Pharma Inc (KITE) including business summary, key statistics, ratios, sector. If you do nothing, you will be auto-enrolled in our premium digital monthly subscription plan and retain complete access for $69 per month.įor cost savings, you can change your plan at any time online in the “Settings & Account” section. To view Kite Pharmas complete valuation and funding history, request access. For a full comparison of Standard and Premium Digital, click here.Ĭhange the plan you will roll onto at any time during your trial by visiting the “Settings & Account” section. Premium Digital includes access to our premier business column, Lex, as well as 15 curated newsletters covering key business themes with original, in-depth reporting. Revenue 22. Standard Digital includes access to a wealth of global news, analysis and expert opinion. Key People Competitors Supplier Risk Kite Pharma financials Kite Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow. Kite flipped 7.5 million shares at 17 each, outgrossing its initial target of 115 million and pricing well above its earlier projected range of 12 to 14. (KITE): Price and Financial Metrics KITE Home News Ratings Charts Kite Pharma, Inc. During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages. 101-250 Post-IPO Equity Delisted 9,502 Highlights Acquisitions 1 Investments 10 Exits 3 Total Funding Amount 335. KITE - Is Its Stock Price A Worthy Investment Learn More.

Kite pharma stock price